Leprosy type 1 reaction (formerly reversal reaction)
- PMID: 26773622
- DOI: 10.1016/j.clindermatol.2015.10.006
Leprosy type 1 reaction (formerly reversal reaction)
Abstract
Nerve damage leading to impairment and permanent disability is the major problem in the course of a leprosy infection. Most of the damage occurs during two types of leprosy reactions, type 1 reaction (T1R) and type 2 reaction (T2R). Timely and adequate treatment may prevent this damage. Particular T1R reactions, however, are often diagnosed too late and are even missed. Clinical symptoms and warning signs are therefore covered, as are the immunology and pathophysiology of nerve damage. The differences between upgrading and downgrading, old terms but still relevant, are explained. Methods to detect reactions and to monitor their treatment are given. Triggering factors, the mechanisms of the reactions, including autoimmunity, and the presence of physical compression are discussed. Treatment over the years is placed in its context, and based on this information a treatment schedule is recommended.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
[Diagnosis and treatment of leprous neuropathy in practice].Rev Neurol (Paris). 2012 Dec;168(12):960-6. doi: 10.1016/j.neurol.2012.09.005. Epub 2012 Nov 3. Rev Neurol (Paris). 2012. PMID: 23131313 Review. French.
-
The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.Lepr Rev. 2005 Mar;76(1):14-34. Lepr Rev. 2005. PMID: 15881033
-
A study on histological features of lepra reactions in patients attending the Dermatology Department of the Government Medical College, Calicut, Kerala, India.Lepr Rev. 2013 Mar;84(1):51-64. Lepr Rev. 2013. PMID: 23741882
-
A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia.PLoS Negl Trop Dis. 2016 Apr 5;10(4):e0004502. doi: 10.1371/journal.pntd.0004502. eCollection 2016 Apr. PLoS Negl Trop Dis. 2016. PMID: 27046330 Free PMC article. Clinical Trial.
-
Leprosy type 1 (reversal) reactions and their management.Lepr Rev. 2008 Dec;79(4):372-86. Lepr Rev. 2008. PMID: 19274984 Review.
Cited by
-
Advances in the Immunology and Genetics of Leprosy.Front Immunol. 2020 Apr 16;11:567. doi: 10.3389/fimmu.2020.00567. eCollection 2020. Front Immunol. 2020. PMID: 32373110 Free PMC article. Review.
-
Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?BMC Infect Dis. 2017 Apr 24;17(1):305. doi: 10.1186/s12879-017-2406-9. BMC Infect Dis. 2017. PMID: 28438129 Free PMC article.
-
Dramatic secukinumab-mediated improvements in refractory leprosy-related neuritis via the modulation of T helper 1 (Th1) and T helper 17 (Th17) immune pathways.Rev Soc Bras Med Trop. 2021 Dec 17;54:e03362021. doi: 10.1590/0037-8682-0336-2021. eCollection 2021. Rev Soc Bras Med Trop. 2021. PMID: 34932761 Free PMC article.
-
Case Report: Upper Thoracic Esophageal Paralysis Accompanying a Type 1 Leprosy Reaction.Am J Trop Med Hyg. 2023 Jun 5;109(2):343-344. doi: 10.4269/ajtmh.22-0799. Print 2023 Aug 2. Am J Trop Med Hyg. 2023. PMID: 37277105 Free PMC article.
-
Immune mediators as plasma biomarkers for identifying household contacts and classifying clinical forms and leprosy reactions.Front Immunol. 2025 Mar 5;16:1513060. doi: 10.3389/fimmu.2025.1513060. eCollection 2025. Front Immunol. 2025. PMID: 40109344 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical